H.E. Prof. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), expressed his gratitude to HRH Prince Mohammed bin Salman bin Abdulaziz Al Saud, the Crown Prince and Prime Minister of the Kingdom of Saudi Arabia, for his blood donation and generous moral support in launching the annual blood donation campaign.
The Saudi Food and Drug Authority (SFDA) is pleased to announce that it is now accepting scientific submissions for the 5th Regulatory Research Day, scheduled for Monday, November 3, 2025, at SFDA headquarters in Riyadh.
Submitted research should focus on one of the following areas: human and veterinary medicines; herbal products; food and animal feed; pesticides; medical devices and supplies; and cosmetics.
The World Health Organization (WHO) has officially designated the Saudi Food and Drug Authority (SFDA) as its Regional Centre for Nutrition Collaboration for the Eastern Mediterranean Region, which encompasses 22 countries. This recognition highlights the SFDA's extensive efforts in implementing robust food and nutrition policies. These policies are designed to enhance public health, improve quality of life, and reduce the prevalence of non-communicable diseases.
The Saudi Food and Drug Authority (SFDA) has been honored with the Silver Award in the seventh cycle of the King Abdulaziz Quality Award (KAQA). This prestigious recognition, presented in the Best Quality Practices in the Government Sector category, was received by H.E. Prof. Dr. Hisham S. Aljadhey, Chief Executive Officer of the SFDA.
As part of its ongoing efforts to strengthen food safety and enhance regulatory performance, the Saudi Food and Drug Authority (SFDA) has developed the Digital Employee tool, an automated solution designed to support the rapid assessment of chemical hazards in food.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, on behalf of himself and the SFDA staff, extended his congratulations to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and HRH Prince Mohammed bin Salman bin Abdulaziz, Crown Prince and Prime Minister—may God protect them—on the successful conclusion of the 2025/1446 AH Hajj season.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, has extended his congratulations to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and HRH Prince Mohammed bin Salman bin Abdulaziz, Crown Prince and Prime Minister, as well as to the Arab and Islamic nations, on the occasion of Eid al-Adha 1446 AH.
H.E. Mr. Fahad bin Abdulrahman Al-Jalajel, Minister of Health and Chairman of the Board of Directors of the Saudi Food and Drug Authority (SFDA), visited the SFDA’s Hajj Operations Centre in Makkah, where he was received by the Chief Executive Officer, H.E. Prof. Dr. Hisham S. Aljadhey.
During the visit, Mr. Al-Jalajel reviewed the efforts undertaken by the SFDA and the progress of its operations during the Hajj season, in line with the approved operational plan and its active contribution to ensuring the safety of food and drug products provided to pilgrims.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, recently undertook a series of inspection visits to critical locations, food establishments, and control centers in Makkah and Jeddah. These visits were integral to the Authority's proactive measures for the upcoming 2025 Hajj season, focusing on evaluating operational readiness and ensuring field compliance.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, today welcomed the President of the Saudi Data and Artificial Intelligence Authority (SDAIA), Dr. Abdullah Al Ghamdi, at the SFDA’s headquarters in Riyadh. The visit focused on strengthening collaboration and direct coordination to leverage data and artificial intelligence (AI) for business development in shared sectors.
